Skip to main content
SpringerLink
Log in

Pharma firms told to end secrecy in drug trials

  • News
  • Published:

From Nature

View current issue Submit your manuscript

Early stages of testing should be made public, say public-health experts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Jim Giles
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Other medical news

Related external links

US federal clinical trials register

International Standardised Randomised Controlled Trial Number Register

International Clinical Trials Registry Platform

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giles, J. Pharma firms told to end secrecy in drug trials. Nature (2006). https://doi.org/10.1038/news060515-16

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news060515-16

  • Springer Nature Limited

Search

Navigation